Header Logo

Connection

MICHAEL VOLK to Male

Back to Details
This is a "connection" page, showing publications MICHAEL VOLK has written about Male.
MICHAEL VOLK
Connection Strength
0.648
Male
  1. Ruptured Hepatocellular Carcinoma following Transarterial Radioembolization. J Vasc Interv Radiol. 2018 09; 29(9):1302-1305.
    View in: PubMed
    Score: 0.024
  2. Current and Future Applications of Telemedicine to Optimize the Delivery of Care in Chronic Liver Disease. Clin Gastroenterol Hepatol. 2018 02; 16(2):157-161.e8.
    View in: PubMed
    Score: 0.023
  3. The "PHS Increased Risk" Label Is Associated With Nonutilization of Hundreds of Organs per Year. Transplantation. 2017 07; 101(7):1666-1669.
    View in: PubMed
    Score: 0.022
  4. The Epidemiology of Cirrhosis in the United States: A Population-based Study. J Clin Gastroenterol. 2015 Sep; 49(8):690-6.
    View in: PubMed
    Score: 0.019
  5. Analytic morphomics identifies predictors of new-onset diabetes after liver transplantation. Clin Transplant. 2015 May; 29(5):458-64.
    View in: PubMed
    Score: 0.019
  6. Variation among United States hospitals in inpatient mortality for cirrhosis. Clin Gastroenterol Hepatol. 2015 Mar; 13(3):577-84; quiz e30.
    View in: PubMed
    Score: 0.018
  7. Pilot test of a patient decision aid about liver transplant organ quality. Liver Transpl. 2014 Jul; 20(7):850-5.
    View in: PubMed
    Score: 0.018
  8. Identifying cirrhosis patients for intensive disease management. Dig Dis Sci. 2014 Jan; 59(1):22-3.
    View in: PubMed
    Score: 0.017
  9. Consequences of perceived stigma among patients with cirrhosis. Dig Dis Sci. 2014 Mar; 59(3):681-6.
    View in: PubMed
    Score: 0.017
  10. Center differences in model for end-stage liver disease exceptions: fairness, local culture, and norms of practice. Liver Transpl. 2013 Dec; 19(12):1287-8.
    View in: PubMed
    Score: 0.017
  11. Systematic bias in surgeons' predictions of the donor-specific risk of liver transplant graft failure. Liver Transpl. 2013 Sep; 19(9):987-90.
    View in: PubMed
    Score: 0.017
  12. Patient knowledge about disease self-management in cirrhosis. Am J Gastroenterol. 2013 Mar; 108(3):302-5.
    View in: PubMed
    Score: 0.016
  13. Improving screening for hepatocellular carcinoma by incorporating data on levels of a-fetoprotein, over time. Clin Gastroenterol Hepatol. 2013 Apr; 11(4):437-40.
    View in: PubMed
    Score: 0.016
  14. Quality improvement measures lead to higher surveillance rates for hepatocellular carcinoma in patients with cirrhosis. Dig Dis Sci. 2013 Apr; 58(4):1157-60.
    View in: PubMed
    Score: 0.016
  15. Non-adherence and graft failure in adult liver transplant recipients. Dig Dis Sci. 2013 Mar; 58(3):824-34.
    View in: PubMed
    Score: 0.016
  16. Declined organ offers in liver transplantation: careful timing or missed opportunity? Gastroenterology. 2012 Nov; 143(5):1141-1143.
    View in: PubMed
    Score: 0.016
  17. How can we improve quality of care for patients with cirrhosis? Gastroenterology. 2012 Jul; 143(1):17-9.
    View in: PubMed
    Score: 0.015
  18. Burden of cirrhosis on older Americans and their families: analysis of the health and retirement study. Hepatology. 2012 Jan; 55(1):184-91.
    View in: PubMed
    Score: 0.015
  19. Organ quality and quality of life after liver transplantation. Liver Transpl. 2011 Dec; 17(12):1443-7.
    View in: PubMed
    Score: 0.015
  20. Patient decision making about organ quality in liver transplantation. Liver Transpl. 2011 Dec; 17(12):1387-93.
    View in: PubMed
    Score: 0.015
  21. Hospital readmissions among patients with decompensated cirrhosis. Am J Gastroenterol. 2012 Feb; 107(2):247-52.
    View in: PubMed
    Score: 0.015
  22. Variation in organ quality between liver transplant centers. Am J Transplant. 2011 May; 11(5):958-64.
    View in: PubMed
    Score: 0.014
  23. Foreigners traveling to the U.S. for transplantation may adversely affect organ donation: a national survey. Am J Transplant. 2010 Jun; 10(6):1468-72.
    View in: PubMed
    Score: 0.013
  24. Attitudes of the American public toward organ donation after uncontrolled (sudden) cardiac death. Am J Transplant. 2010 Mar; 10(3):675-80.
    View in: PubMed
    Score: 0.013
  25. Public health impact of antiviral therapy for hepatitis C in the United States. Hepatology. 2009 Dec; 50(6):1750-5.
    View in: PubMed
    Score: 0.013
  26. Geographic variation in organ availability is responsible for disparities in liver transplantation between Hispanics and Caucasians. Am J Transplant. 2009 Sep; 9(9):2113-8.
    View in: PubMed
    Score: 0.013
  27. Modified Charlson comorbidity index for predicting survival after liver transplantation. Liver Transpl. 2007 Nov; 13(11):1515-20.
    View in: PubMed
    Score: 0.011
  28. Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: a comparison of AFP, DCP, and AFP-L3. Cancer Biomark. 2007; 3(2):79-87.
    View in: PubMed
    Score: 0.011
  29. The Liver Transplant Comorbidity Index (LTCI): A composite index of ambulatory pre-LT factors to identify patients at increased risk of post-LT mortality. Hepatology. 2026 Feb 01; 83(2):294-303.
    View in: PubMed
    Score: 0.009
  30. Liver transplantation provides survival benefit at all levels of frailty: From the Multicenter Functional Assessment in Liver Transplantation Study. Hepatology. 2025 Apr 01; 81(4):1269-1275.
    View in: PubMed
    Score: 0.009
  31. Loneliness in adults awaiting liver transplantation at 7 U.S. transplant centers. Ann Hepatol. 2022 Sep-Oct; 27(5):100718.
    View in: PubMed
    Score: 0.008
  32. Disease Knowledge, Health-Related Quality of Life, and Lifestyle Behavior Change in Patients with Nonalcoholic Fatty Liver Disease: Impact of an Educational Intervention. Dig Dis Sci. 2022 06; 67(6):2123-2133.
    View in: PubMed
    Score: 0.007
  33. Utility of Framingham Score for Optimizing Preoperative Evaluation Among Patients Undergoing Liver Transplant Evaluation. Transplant Proc. 2021 Jun; 53(5):1616-1621.
    View in: PubMed
    Score: 0.007
  34. Association of Frailty and Sex With Wait List Mortality in Liver Transplant Candidates in the Multicenter Functional Assessment in Liver Transplantation (FrAILT) Study. JAMA Surg. 2021 03 01; 156(3):256-262.
    View in: PubMed
    Score: 0.007
  35. Bariatric surgery and the risk of alcohol-related cirrhosis and alcohol misuse. Liver Int. 2021 05; 41(5):1012-1019.
    View in: PubMed
    Score: 0.007
  36. Identifying an Optimal Liver Frailty Index Cutoff to Predict Waitlist Mortality in Liver Transplant Candidates. Hepatology. 2021 03; 73(3):1132-1139.
    View in: PubMed
    Score: 0.007
  37. Introducing Palliative Care within the Treatment of End-Stage Liver Disease: The Study Protocol of a Cluster Randomized Controlled Trial. J Palliat Med. 2019 09; 22(S1):34-43.
    View in: PubMed
    Score: 0.006
  38. Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma. Gastroenterology. 2019 11; 157(5):1253-1263.e2.
    View in: PubMed
    Score: 0.006
  39. Predictors of Systolic Heart Failure and Mortality Following Orthotopic Liver Transplantation: a Single-Center Cohort. Transplant Proc. 2019 Jul - Aug; 51(6):1950-1955.
    View in: PubMed
    Score: 0.006
  40. Gender Disparities in Alcohol Use Disorder Treatment Among Privately Insured Patients with Alcohol-Associated Cirrhosis. Alcohol Clin Exp Res. 2019 02; 43(2):334-341.
    View in: PubMed
    Score: 0.006
  41. Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multicenter Study. Gastroenterology. 2019 05; 156(6):1675-1682.
    View in: PubMed
    Score: 0.006
  42. Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study. Gastroenterology. 2019 05; 156(6):1683-1692.e1.
    View in: PubMed
    Score: 0.006
  43. Factors Associated with Survival of Patients With Severe Acute-On-Chronic Liver Failure Before and After Liver?Transplantation. Gastroenterology. 2019 Apr; 156(5):1381-1391.e3.
    View in: PubMed
    Score: 0.006
  44. Transplantation of hepatitis C virus (HCV) antibody positive, nucleic acid test negative donor kidneys to HCV negative patients frequently results in seroconversion but not HCV viremia. Am J Transplant. 2018 10; 18(10):2451-2456.
    View in: PubMed
    Score: 0.006
  45. The high burden of alcoholic cirrhosis in privately insured persons in the United States. Hepatology. 2018 09; 68(3):872-882.
    View in: PubMed
    Score: 0.006
  46. Misconceptions, preferences and barriers to alcohol use disorder treatment in alcohol-related cirrhosis. J Subst Abuse Treat. 2018 08; 91:20-27.
    View in: PubMed
    Score: 0.006
  47. VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study. Clin Lymphoma Myeloma Leuk. 2018 01; 18(1):e61-e67.
    View in: PubMed
    Score: 0.006
  48. Analysis of Liver Offers to Pediatric Candidates on the Transplant Wait List. Gastroenterology. 2017 10; 153(4):988-995.
    View in: PubMed
    Score: 0.005
  49. Exploratory study into the unmet supportive needs of people diagnosed with cirrhosis in Queensland, Australia. Intern Med J. 2017 Apr; 47(4):429-435.
    View in: PubMed
    Score: 0.005
  50. Performance-Based Measures Associate With Frailty in Patients With End-Stage Liver Disease. Transplantation. 2016 Dec; 100(12):2656-2660.
    View in: PubMed
    Score: 0.005
  51. Access to Subspecialty Care And Survival Among Patients With Liver Disease. Am J Gastroenterol. 2016 06; 111(6):838-44.
    View in: PubMed
    Score: 0.005
  52. Randomized Clinical Trial Comparing Proton Beam Radiation Therapy with Transarterial Chemoembolization for Hepatocellular Carcinoma: Results of an Interim Analysis. Int J Radiat Oncol Biol Phys. 2016 May 01; 95(1):477-482.
    View in: PubMed
    Score: 0.005
  53. Estimation of Liver Transplant Related Survival Benefit: the Devil Is in The Details. Gastroenterology. 2016 Feb; 150(2):534-5.
    View in: PubMed
    Score: 0.005
  54. Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study. J Hepatol. 2015 Mar; 62(3):617-24.
    View in: PubMed
    Score: 0.005
  55. Applying reinforcement learning techniques to detect hepatocellular carcinoma under limited screening capacity. Health Care Manag Sci. 2015 Sep; 18(3):363-75.
    View in: PubMed
    Score: 0.005
  56. Neoadjuvant stereotactic body radiation therapy, capecitabine, and liver transplantation for unresectable hilar cholangiocarcinoma. Liver Transpl. 2014 Jan; 20(1):81-8.
    View in: PubMed
    Score: 0.004
  57. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list. J Hepatol. 2014 Feb; 60(2):290-7.
    View in: PubMed
    Score: 0.004
  58. Clinical yield of diagnostic endoscopic retrograde cholangiopancreatography in orthotopic liver transplant recipients with suspected biliary complications. Liver Transpl. 2012 Dec; 18(12):1479-84.
    View in: PubMed
    Score: 0.004
  59. Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis. Cancer Epidemiol Biomarkers Prev. 2012 May; 21(5):793-9.
    View in: PubMed
    Score: 0.004
  60. Improving access to colorectal cancer screening through medical philanthropy: feasibility of a flexible sigmoidoscopy health fair for uninsured patients. Am J Gastroenterol. 2011 Oct; 106(10):1741-6.
    View in: PubMed
    Score: 0.004
  61. Patient involvement in healthcare is associated with higher rates of surveillance for hepatocellular carcinoma. J Clin Gastroenterol. 2011 Sep; 45(8):727-32.
    View in: PubMed
    Score: 0.004
  62. The survival benefit of liver transplantation in hepatocellular carcinoma patients. Dig Liver Dis. 2010 Sep; 42(9):642-9.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.